Dymond, Amy
Arnaud, Alix
Agirrezabal, Ion
Green, Will
Funding for this research was provided by:
Sanofi
Article History
Received: 11 February 2025
Accepted: 12 October 2025
First Online: 5 November 2025
Declarations
:
: Amy Dymond is an employee of York Health Economics Consortium who was paid consultancy fees by Sanofi. Alix Arnaud is an employee of Sanofi and may hold stock/stock options in Sanofi. Ion Agirrezabal is an employee of Sanofi and may hold stock/stock options in Sanofi. Will Green is an employee of York Health Economics Consortium who was paid consultancy fees by Sanofi.
: All the source studies had ethical approval and were performed in accordance with the principles of the Declaration of Helsinki and local regulations.
: Patients were required to provide informed consent to participate in the source studies used in this post hoc analysis and modeling of data already collected.
: Not applicable.
: Qualified researchers may request access to patient-level data and related study documents. Patient-level data will be anonymized, and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi’s data-sharing criteria, eligible studies, and process for requesting access can be found at: .
: Not applicable.
: AA, AD, IA, and WG made substantial contributions to the analysis and interpretation of the data. AA made substantial contributions to study conception and design and to the acquisition of data. All authors were involved in drafting the work or revising it critically for important intellectual content, and in final approval of the version to be published. All authors have agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Sobi and Sanofi reviewed and provided feedback on the manuscript.